Related Party Transactions

12 Months Ended

Dec. 31, 2025

Related Party Transactions [Abstract]

Related Party Transactions

NOTE 18. Related Party Transactions

Significant Stockholders

During the year ended December 31, 2023, the Company recognized general and administrative expenses of $1.7 million to administered secondary offerings of shares of its common stock sold by CD&R and did not receive any proceeds from any sale of shares of its common stock. CD&R controls Gentiva Health Services (“Gentiva”). Gentiva wholly owns Illumia Health, LLC (“Illumia”). For the year ended December 31, 2025, the Company incurred expenses of $8.4 million for provider services delivered by Illumia. As of December 31, 2025, the Company had an outstanding receivable from Illumia of $5.2 million. The Company has not entered into any other material transactions with CD&R for the periods presented.

Equity Method Investments

For the years ended December 31, 2025, 2024, and 2023, the Company incurred expenses of $7.0 million, $8.0 million, and $8.9 million, respectively for provider services delivered by Population Health, LLC, which is accounted for under the equity method based on a 49% equity ownership interest held by the Company. As of December 31, 2025 and 2024, the Company had an outstanding payable to Population Health, LLC of $0.6 million and $1.2 million, respectively.

For the years ended December 31, 2025, 2024, and 2023, the Company recognized revenue of $3.5 million, $3.9 million, and $1.6 million, respectively, for technology services rendered to its CMS ACO Models investments. For the years ended December 31, 2025, 2024, and 2023, the Company recognized other income of $50.1 million, $14.9 million, and $2.9 million, respectively, for operational and administrative services provided by the Company. As of December 31, 2025 and 2024, the Company had an outstanding receivable from the CMS ACO Models of $51.3 million and $7.0 million, respectively.